Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **skin moisture barrier** refers to the outermost layer of the epidermis—primarily the **stratum corneum**—which acts as a selectively permeable shield that prevents excessive water loss from the body while protecting underlying tissues from environmental insults such as pathogens, chemicals, allergens, and mechanical stress[1][2][4]. The stratum corneum is composed mainly of dead keratin-filled cells called *corneocytes* ("bricks") embedded in a lipid matrix ("mortar") made up primarily of ceramides, cholesterol, and fatty acids. This structure is further supported by proteins like filaggrin and involucrin that help maintain its integrity[2][3][5]. The skin moisture barrier is not a single molecule or receptor but rather a complex physical structure essential for maintaining hydration and overall skin health. It also plays roles in immune defense by supporting an acidic environment hostile to pathogens while fostering beneficial microbiota[5][7]. Disruption or dysfunction can lead to increased transepidermal water loss (TEWL), dryness, inflammation (as seen in eczema), increased susceptibility to infection or allergen penetration. Because it is not a discrete molecular target such as an enzyme or receptor but rather an anatomical-functional concept describing tissue organization at the microscopic level,[1][2] "skin moisture barrier" should not be considered a canonical therapeutic target. Instead therapies aim to support its function through topical agents that restore lipids or attract/retain moisture. > "The stratum corneum forms a 'brick-and-mortar' structure... The bricks are flattened dead cells called corneocytes; the mortar consists mainly of lipids... Together they create an effective permeability barrier against both water loss from within and entry by external substances."[1][2] In summary: **"Skin moisture barrier"** describes an essential physiological property conferred by the stratum corneum's unique architecture—not a specific molecule/receptor—and thus does not fit standard drug-target classification schemes.
Restoration or enhancement of lipid matrix and natural moisturizing factors
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Stratum corneum (skin moisture barrier).